🔎 Trials Near Me

Home › Endometrial Cancer › Washington › Spokane Valley

Endometrial Cancer clinical trials in Spokane Valley, WA

4 studies for Endometrial Cancer are looking for participants at sites in and around Spokane Valley (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

RecruitingPhase 3
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi away
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi away
Ages 18 and older · Women · Updated Sep 30, 2026 · NCT07198074

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

RecruitingPhase 3
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi away
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi away
Ages 18 and older · Women · Updated Sep 29, 2026 · NCT05256225

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

RecruitingPhase 2
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi away
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi away
All ages · All sexes · Updated Sep 29, 2026 · NCT05564377

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

RecruitingPhase 2
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls · 14 mi away
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene · 21 mi away
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT05112601

Endometrial Cancer trials in other cities

Other studies in Spokane Valley

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.